• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

adhd medication uk Medication During Pregnancy and Breastfeeding

Women suffering from ADHD have to make a difficult choice on whether to keep or stop taking ADHD medication during pregnancy and breastfeeding. There aren't many studies on how exposure to ADHD for a long time could affect the fetus.

A recent study published in Molecular Psychiatry shows that children exposed to ADHD medication during the uterus don't develop neurological conditions like impaired vision or hearing seizures, febrile seizures or IQ impairment. The authors acknowledge that more high-quality studies are required.

Risk/Benefit Analysis

Women who are pregnant and taking ADHD medications need to balance the advantages of using them against the risks to the foetus. Physicians do not have the information needed to make unequivocal recommendations but they can provide information regarding risks and benefits that aid pregnant women in making informed decisions.

A study published in Molecular Psychiatry found that women who used ADHD medications in early pregnancy did not face a significantly increased risk of fetal cardiac malformations or major structural birth defects. Researchers used a vast, population-based case-control study to determine the prevalence of major structural birth defects in babies born to mothers who had taken stimulants during early pregnancy, as well as those who had not. Pediatric cardiologists, clinical geneticists and other experts examined the cases to confirm that the classification was accurate and to reduce any bias.

However, the researchers' study was not without its flaws. The most important issue was that they were unable to distinguish the effects of the medication from those of the disorder at hand. This limitation makes it difficult to determine whether the limited associations observed in the groups that were exposed result from medication use or comorbidities that cause confusion. The researchers did not look at long-term outcomes for offspring.

The study found that infants whose mother took ADHD medication during pregnancy were at a slightly greater risk of being admitted to the neonatal care unit (NICU) as compared to those whose mothers did not take any medication during pregnancy or had discontinued taking their medication prior to or during pregnancy. This was due to central nervous system disorders, and the higher risk of admission was not found to be affected by the type of stimulant medications were used during pregnancy.

Women who were taking stimulant ADHD medications during pregnancy also had a higher likelihood of having to have an emergency caesarean section or having the baby was not scoring well on the Apgar scale (less than 7). These increases did appear to be independent of the type of medication used during pregnancy.

Researchers suggest that the minor risks posed by the use of ADHD medications during early pregnancies could be offset by the greater benefits for baby and mother of continued treatment for the woman's disorder. Physicians should talk to their patients about this issue and try to help them develop coping with adhd without medication skills that could reduce the impact of her disorder in her daily life and relationships.

Interactions with Medication

As more women than ever are diagnosed with ADHD and being treated with medication, the issue of whether where to get prescribed adhd medication keep or stop treatment during pregnancy is a question that more and more physicians confront. These decisions are frequently made without clear and reliable evidence. Instead, doctors must take into account their own experience in conjunction with the experiences of other physicians and the research on the subject.

The issue of possible risks to the infant can be extremely difficult. The research that has been conducted on this topic is based on observations instead of controlled studies and the results are contradictory. Most studies restrict their analysis to live-births, which could underestimate the severity of teratogenic effects that can lead to terminations or abortions of pregnancy. The study that is discussed in this journal club addresses these limitations by looking at data from both live and deceased births.

The conclusion is that while certain studies have demonstrated an association between ADHD medications and the risk of certain birth defects, other studies have not found any evidence of a link and the majority of studies have a neutral or slight negative effect. In each case an in-depth study of the risks and benefits should be conducted.

For women suffering from ADHD who suffer from ADHD, the decision to stop medication can be difficult, if not impossible. In fact, in an article published in the Archives of Women's Mental Health psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can lead to increased depression, feelings of isolation and family conflict for patients with ADHD. Additionally, the loss of medication may affect the ability to perform jobs and drive safely which are essential aspects of a normal life for a lot of people with ADHD.

She recommends women who can prescribe adhd medication are unsure about whether or not to stop taking medication because of their pregnancy, consider educating family members, friends and colleagues about the condition, its effects on daily life, and the benefits of keeping the current treatment plan. In addition, educating them can make the woman feel more comfortable as she struggles with her decision. Certain medications can pass through the placenta. If a woman decides not to take her ADHD medication while pregnant and breastfeeding, it is important to be aware that the drug may be transferred to her infant.

Risk of Birth Defects

As the use of ADHD medication to treat the symptoms of attention deficit hyperactivity disorder (ADHD) grows there are concerns over the impact that these drugs could have on the fetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge on this issue. Researchers used two huge data sets to examine over the counter adhd medication uk 4.3 million pregnancy and determine if stimulant medication use caused birth defects. Researchers discovered that, while the risk overall is low, the first trimester ADHD medication exposure was associated with slightly higher risk of specific heart defects like ventriculoseptal defects.

The researchers of the study could not discover any connection between early use of medication and other congenital anomalies such as facial deformities or club feet. The results are consistent with previous studies that have shown an increase, but not significant, in the risk of heart malformations in women who started taking ADHD medications before pregnancy. This risk increased during the latter part of pregnancy, when a lot of women begin to discontinue their ADHD medication.

Women who were taking ADHD medication during the first trimester were more likely to need a caesarean or have an insufficient Apgar after birth and have a baby who needed breathing assistance after birth. The researchers of the study could not remove bias in selection since they limited the study to women without other medical conditions that might have contributed to the findings.

The researchers hope their research will help inform the clinical decisions of physicians who treat pregnant women. They recommend that, while the discussion of the risks and benefits is crucial, the decision to stop or maintain medication should be based on the woman's requirements and the severity of her ADHD symptoms.

The authors also advise that while discontinuing the medications is an alternative, it is not a recommended practice because of the high rate of depression and other mental health problems for women who are expecting or who are recently post-partum. Additionally, research suggests that women who stop taking their medications will have a harder adjustment to life without them once the baby is born.

Nursing

The responsibilities of being a new mother can be overwhelming. Women suffering from ADHD are often faced with a number of difficulties when they must deal with their symptoms, attend doctor appointments and prepare for the birth of their child and adjust to new routines. Many women decide to continue taking their ADHD medication during pregnancy.

The majority of stimulant medications are absorbed through breast milk in small quantities, so the risk for breastfeeding infant is minimal. However, the rate of medication exposure to the infant can differ based on dosage, frequency it is administered, and the time of the day it is administered. Additionally, individual medications enter the infant's system differently through the gastrointestinal tract as well as breast milk. The impact of this on a newborn isn't fully understood.

Due to the absence of evidence, some doctors may be inclined to discontinue stimulant medication during the pregnancy of a woman. This is a difficult choice for the patient, who must weigh the benefit of continuing her medication against the possible dangers to the foetus. In the meantime, until more information is available, doctors should inquire with all pregnant patients about their experience with ADHD and if they are planning or taking to take medication during the perinatal period.

A increasing number of studies have proven that most women can safely continue taking their adhd medication without prescribing - More Help, medication during pregnancy and breastfeeding. This has led to more and more patients are choosing to do so and, after consulting with their doctor, they have found that the benefits of maintaining their current medication outweigh any risks.

Women with ADHD who are planning to breastfeed should seek the advice of a specialist psychiatrist prior to becoming pregnant. They should discuss their medication with their prescriber and discuss the pros and cons of continued treatment, including non-pharmacological management strategies. Psychoeducation is also needed to help pregnant women suffering from ADHD be aware of the symptoms and the underlying disorder. They should also learn about treatment options and build strategies for coping. This should involve a multidisciplinary approach, which includes the GP, obstetricians and psychiatry. Counselling for pregnancy should include the discussion of a plan for management for both mother and child, as well as monitoring for signs of deterioration and when necessary, making adjustments to the medication regimen.